Bioinova

Peter completed his medical and postgraduate (Molecular Genetics, Biology and Virology program) studies at the 3rd and 2nd Medical Faculty of Charles University in Prague.
2002–2008: RIKEN Brain Science Institute, Wako-shi, Japan
2009–2011: National Institutes of Health, National Cancer Institute, Bethesda, MD, USA
2012–2016: Mayo Clinic, Department of Neuroscience, Jacksonville, FL, USA
Since 2016: CEO of Bioinova

Ivana completed her studies at the Faculty of Chemical Technology of Pardubice University. For more than 35 years, she has been working in quality control of immunological products manufactured by a Czech pharmaceutical company where she became a Qualified person in 1998. Ivana is now using her extensive experience to overseeing ATMPs production, cell and tissue harvesting, medical device manufacturing, and the operation of a diagnostic laboratory, ensuring compliance with legislation and regulatory requirements.

Katerina graduated from the Faculty of Science of Charles University in Prague (Biochemistry) and obtained her postdoctoral degree at the 1st Medical Faculty of Charles University in Neuroscience. As a visiting fellow, she had positions in Seattle, United States; Budapest, Hungary; and Cologne, Germany. After her studies, she worked at the Institute of Experimental Medicine of the Czech Academy of Sciences for 14 years. Since 2011, Katerina has been the Head of the Quality Control Department, since 2018, Qualified Person in Bioinova. In 2019, she also became the Responsible Person for the Tissue Establishment. She currently works as a Clinical Research Associate.

Jana graduated at the University of Chemistry and Technology in Prague (Biotechnology of Pharmaceuticals). Within her studies she had been focusing on targeted therapy of cancer and specifically, testing of novel photosensitive molecules in cell cultures. During her last year at the university, she started to work in Bioinova and subsequently joined the production team full-time in 2018. Her main RnD focus is the cryopreservation of stem cells.

Barbora graduated from the Czech University of Life Sciences Prague (Reproductive Biotechnologies). After completion of her studies, she worked in the Quality Control Department where she was responsible for quality control procedures of stem-cell-based products in veterinary medicine. She joined Bioinova Quality Control Department in 2021. Her main focus is quality control procedures (qPCR, flow cytometry) of ATMPs and custom quality control.

Michael is a specialist with several years of experience in molecular diagnostics, microbiology, and genetic methods. He graduated in Biochemistry and Biotechnology, followed by General and Applied Biochemistry at the University of Chemistry and Technology in Prague. Michael has built his professional career in dynamic laboratory environments, including GENNET s.r.o. and Bioinova a.s., where he worked as a research specialist focusing on diagnostic microbiological and genetic methods. Since 2024, he has been leading the Diagnostic Laboratory.

David has been with Bioinova since July 2023, initially overseeing the BioCanim project focused on the development of intratumoral immunotherapy. Before joining Bioinova, he spent many years at the First Faculty of Medicine, Charles University, where he specialized in the experimental development of cancer therapies. David has extensive experience in the biological evaluation of systems for targeted delivery of anticancer drugs and their effects on the immune system. During his career, he also worked as a researcher at renowned international institutions, including the University of Oxford, the University of Minnesota, and the Nebraska Medical Center in the USA. Beyond academia, he founded and led Sven BioLabs, a company distributing products for research laboratories, as well as a pharmaceutical start-up developing a drug against tuberculosis. At Bioinova, he is responsible for the Tissue Bank, where he can apply his experience from both academic and commercial spheres.

Hana graduated from the Faculty of Science at Masaryk University in Brno and subsequently earned a Ph.D. in Drug Safety and Quality at the Faculty of Pharmacy. Since 2014, she has held various positions in companies that produce medicinal products and medical devices, participated in international collaborations, and led several development projects. At Bioinova, she serves as a consultant in the areas of clinical trials and regulatory affairs.